Article
Regulatory Approved Monoclonal Antibodies Contain Framework Mutations Predicted From Human Antibody Repertoires.
Frontiers in immunology - 1 Jan 2021
Petersen Brian M, Ulmer Sophia A, Rhodes Emily R, Gutierrez-Gonzalez Matias F, Dekosky Brandon J, Sprenger Kayla G, Whitehead Timothy A
Abstract excerpt
Monoclonal antibodies (mAbs) are an important class of therapeutics used to treat cancer, inflammation, and infectious diseases. Identifying highly developable mAb sequences in silico could greatly reduce the time and cost required for therapeutic mAb development. Here, we present position-specific scoring matrices (PSSMs) for antibody framework mutations developed using baseline human antibody repertoire...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
